$1.44
2.13% day before yesterday
Nasdaq, Jul 11, 10:00 pm CET
ISIN
US19516Q2084
Symbol
CLGN
Sector
Industry

Collplant Holdings ADR Stock price

$1.44
-0.29 16.76% 1M
-2.49 63.34% 6M
-2.16 60.00% YTD
-3.66 71.76% 1Y
-7.02 82.98% 3Y
-7.66 84.18% 5Y
-16.05 91.77% 10Y
-17.03 92.20% 20Y
Nasdaq, Closing price Fri, Jul 11 2025
+0.03 2.13%
ISIN
US19516Q2084
Symbol
CLGN
Sector
Industry

Key metrics

Basic
Market capitalization
$18.3m
Enterprise Value
$7.6m
Net debt
positive
Cash
$10.7m
Shares outstanding
11.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
7.4 | 1.7
EV/Sales
3.1 | 0.7
EV/FCF
negative
P/B
1.5
Financial Health
Equity Ratio
72.0%
Return on Equity
-123.4%
ROCE
-100.4%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$2.5m | $10.8m
EBITDA
$-13.6m | -
EBIT
$-14.6m | $-5.2m
Net Income
$-13.9m | $-3.6m
Free Cash Flow
$-12.4m
Growth (TTM | estimate)
Revenue
-76.7% | 1,979.2%
EBITDA
-88.0% | -
EBIT
-75.1% | 69.3%
Net Income
-84.9% | 78.2%
Free Cash Flow
-260.0%
Margin (TTM | estimate)
Gross
48.7%
EBITDA
-548.9% | -
EBIT
-589.4%
Net
-560.9% | -33.5%
Free Cash Flow
-502.3%
More
EPS
$-1.2
FCF per Share
$-1.1
Short interest
0.9%
Employees
57
Rev per Employee
$10.0k
Show more

Is Collplant Holdings ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Collplant Holdings ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Collplant Holdings ADR forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Collplant Holdings ADR forecast:

Buy
86%
Hold
14%

Financial data from Collplant Holdings ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2.47 2.47
77% 77%
100%
- Direct Costs 1.27 1.27
43% 43%
51%
1.20 1.20
86% 86%
49%
- Selling and Administrative Expenses 5.56 5.56
7% 7%
225%
- Research and Development Expense 10 10
5% 5%
413%
-14 -14
88% 88%
-549%
- Depreciation and Amortization 1 1
9% 9%
40%
EBIT (Operating Income) EBIT -15 -15
75% 75%
-590%
Net Profit -14 -14
85% 85%
-562%

In millions USD.

Don't miss a Thing! We will send you all news about Collplant Holdings ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Collplant Holdings ADR Stock News

Neutral
PRNewsWire
about one month ago
CollPlant's proprietary rhCollagen to be used in clinical and commercial applications REHOVOT, Israel , June 9, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its plant-derived, Type I recombinant human collagen (rhCollagen)  for tissue regeneration and medical aesthetics, tod...
Neutral
PRNewsWire
about one month ago
- Further protection granted in key territory applying to the significant and growing aesthetic and reconstructive markets - REHOVOT, Israel , June 4, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aestheti...
Neutral
PRNewsWire
about one month ago
REHOVOT, Israel , May 30, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 1,200,002 of...
More Collplant Holdings ADR News

Company Profile

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The company's products include VergenixSTR, VergenixFG, and CollPlant Surgical Matrix. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

Head office Israel
CEO Mr. Tal
Employees 57
Founded 2004
Website www.collplant.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today